Analysts Offer Insights on Healthcare Companies: Cellectis SA (CLLS), Agenus (AGEN) and OrthoPediatrics (KIDS)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Cellectis SA (CLLS – Research Report), Agenus (AGEN – Research Report) and OrthoPediatrics (KIDS – Research Report).

Cellectis SA (CLLS)

In a report released today, Soumit Roy from JonesTrading maintained a Hold rating on Cellectis SA. The company’s shares closed last Tuesday at $2.49.

According to TipRanks.com, Roy ‘s ranking currently consits of 0 on a 0-5 ranking scale, with an average return of -6.6% and a 25.8% success rate. Roy covers the Healthcare sector, focusing on stocks such as Day One Biopharmaceuticals, Acrivon Therapeutics, Inc., and Deciphera Pharmaceuticals.

Currently, the analyst consensus on Cellectis SA is a Strong Buy with an average price target of $9.00.

See today’s best-performing stocks on TipRanks >>

Agenus (AGEN)

In a report released today, Emily Bodnar from H.C. Wainwright maintained a Buy rating on Agenus, with a price target of $8.00. The company’s shares closed last Tuesday at $0.82, close to its 52-week low of $0.73.

According to TipRanks.com, Bodnar ‘s ranking currently consits of 0 on a 0-5 ranking scale, with an average return of -11.7% and a 26.8% success rate. Bodnar covers the Healthcare sector, focusing on stocks such as Acrivon Therapeutics, Inc., Gracell Biotechnologies, and TransCode Therapeutics.

Agenus has an analyst consensus of Strong Buy, with a price target consensus of $8.00.

OrthoPediatrics (KIDS)

BTIG analyst Ryan Zimmerman maintained a Buy rating on OrthoPediatrics today and set a price target of $43.00. The company’s shares closed last Tuesday at $28.20.

According to TipRanks.com, Zimmerman is a 4-star analyst with an average return of 2.7% and a 38.5% success rate. Zimmerman covers the Healthcare sector, focusing on stocks such as GE Healthcare Technologies Inc, Treace Medical Concepts, and Organogenesis Holdings.

The word on The Street in general, suggests a Strong Buy analyst consensus rating for OrthoPediatrics with a $44.67 average price target, which is a 65.4% upside from current levels. In a report released today, JMP Securities also reiterated a Buy rating on the stock with a $60.00 price target.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on CLLS:

• Cellectis Reports Financial Results for Third Quarter and First Nine Months 2023
• CLLS Upcoming Earnings Report: What to Expect?
• Monthly information on share capital and company voting rights
• Biotech Alert: Searches spiking for these stocks today
• Cellectis to Present Preliminary Results of NATHALI_01 and Updated Results of the BALLI_01 Phases I Trials at the American Society of Hematology (ASH) 65th Annual Meeting